EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Histone modification: Biomarkers and potential therapies in colorectal cancer

Xin An, Xiaohua Lan, Zizhen Feng, Xiaohong Li, Qisheng Su iD

Annals of Human Genetics · 2023

DOI: 10.1111/ahg.12528 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Human Genetics, 2023. Verfasst von Xin An und 4 weiteren Autor:innen. Beteiligte Einrichtung: First College for Clinical Medicine, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Histones, Histone Code. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Innovation and entrepreneurship training program for college students of Guangxi Medical University, the self-funded scientific research project of Guangxi Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complex mechanism of colorectal cancer development is closely associated with epigenetic modifications and is caused by overexpression and/or inactivation of oncogenes. Histone modifying enzymes catalyze histone modifications to alter gene expression, which plays a crucial role in the development and progression of colorectal cancer. Currently, there is more frequent study on histone acetylation, methylation, and phosphorylation, and their mechanisms in colorectal cancer development are clearer. This article elaborates on the role of histone modification in epigenetics in colorectal cancer development and discusses recent advances in using it as biomarkers and therapeutic targets for the treatment of colorectal cancer. The review aims to demonstrate the significant role of histone modification as a new therapeutic target in colorectal cancer and provides insights into the novel diagnostic and therapeutic options it offers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorHistonesHistone CodeHumansEpigenesis, GeneticAcetylation

Stichwörter der Autor:innen

biomarkerscolorectal cancerdrug targetsepigeneticshistone modifications

Substanzen

Biomarkers, TumorHistones

Autor:innen und Institutionen

  • First College for Clinical Medicine, Guangxi Medical University, Nanning, Guangxi, China.
  • School of Basic Medicine, Guangxi Medical University, Nanning, Guangxi, China.
  • Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

ORCID-Profile: Qisheng Su

Förderung

  • Innovation and entrepreneurship training program for college students of Guangxi Medical University
  • the self-funded scientific research project of Guangxi Health Commission

Zitieren

APA

An, X., Lan, X., Feng, Z., Li, X., & Su, Q. (2023). Histone modification: Biomarkers and potential therapies in colorectal cancer. Annals of Human Genetics. https://doi.org/10.1111/ahg.12528

Vancouver

An X, Lan X, Feng Z, Li X, Su Q. Histone modification: Biomarkers and potential therapies in colorectal cancer. Annals of Human Genetics. 2023. doi:10.1111/ahg.12528

BibTeX
@article{An2023,
  author = {An, Xin and Lan, Xiaohua and Feng, Zizhen and Li, Xiaohong and Su, Qisheng},
  title = {Histone modification: Biomarkers and potential therapies in colorectal cancer},
  journal = {Annals of Human Genetics},
  year = {2023},
  doi = {10.1111/ahg.12528}
}
Kostenlos starten →